USTEKINUMAB
ustekinumab 90 mg/mL injection, 1 mL syringe
USTEKINUMAB (13261Y)
13261Y
Manner of administration:Injection
Restriction
Indication: Moderate to severe ulcerative colitis
Treatment phase: First continuing treatment
Restriction
Indication: Moderate to severe ulcerative colitis
Treatment phase: Subsequent continuing treatment
Restriction
Indication: Moderate to severe ulcerative colitis
Treatment phase: First continuing, Subsequent continuing treatment - balance of supply
